Noncutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy

被引:1
作者
Asdourian, Maria S. [1 ,2 ]
Jacoby, Ted V. [2 ,3 ]
Shah, Nishi [2 ,4 ]
Otto, Tracey [5 ]
Thompson, Leah L. [1 ,2 ]
Dee, Edward Christopher [6 ]
Reynolds, Kerry L. [1 ,7 ]
Semenov, Yevgeniy R. [1 ,2 ]
Chen, Steven T. [1 ,2 ,8 ]
机构
[1] Harvard Med Sch, Boston, MA USA
[2] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA USA
[3] Univ Hawaii Manoa, John A Burns Sch Med, Honolulu, HI USA
[4] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA
[5] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA
[6] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY USA
[7] Massachusetts Gen Hosp, Dept Med, Div Hematol & Oncol, Canc Ctr, Boston, MA USA
[8] Massachusetts Gen Hosp, Dept Dermatol, 50 Staniford St, Boston, MA 02114 USA
关键词
cutaneous immune-related adverse event; dermatologic toxicity; immune checkpoint inhibitor; immunotherapy; multisystem toxicity; noncutaneous immune-related adverse event; oncodermatology; overall survival; progression-free survival;
D O I
10.1016/j.jaad.2022.12.049
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:1368 / 1370
页数:3
相关论文
共 5 条
[1]  
Cho Y, 2022, SCI REP-UK, V12, P1
[2]   Association of Immune Related Adverse Events With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Cancers: A Systemic Review and Meta-analysis [J].
Fan, Yong ;
Xie, Wenhui ;
Huang, Hong ;
Wang, Yunxia ;
Li, Guangtao ;
Geng, Yan ;
Hao, Yanjie ;
Zhang, Zhuoli .
FRONTIERS IN ONCOLOGY, 2021, 11
[3]   Histologic subtype of cutaneous immune-related adverse events predicts overall survival in patients receiving immune checkpoint inhibitors [J].
Hirotsu, Kelsey E. ;
Scott, Madeleine K. D. ;
Marquez, Cesar ;
Tran, Anhthy T. ;
Rieger, Kerri E. ;
Novoa, Roberto A. ;
Robinson, William H. ;
Kwong, Bernice Y. ;
Zaba, Lisa C. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) :651-653
[4]  
Lee CKM, 2018, J AM ACAD DERMATOL, V79, P1047, DOI [10.1016/j.placenta.2018.05.035, 10.1016/j.jaad.2018.05.035]
[5]   Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung Cancer [J].
Shankar, Bairavi ;
Zhang, Jiajia ;
Naqash, Abdul Rafeh ;
Forde, Patrick M. ;
Feliciano, Josephine L. ;
Marrone, Kristen A. ;
Ettinger, David S. ;
Hann, Christine L. ;
Brahmer, Julie R. ;
Ricciuti, Biagio ;
Owen, Dwight ;
Toi, Yukihiro ;
Walker, Paul ;
Otterson, Gregory A. ;
Patel, Sandip H. ;
Sugawara, Shunichi ;
Naidoo, Jarushka .
JAMA ONCOLOGY, 2020, 6 (12) :1952-1956